Pastāsti draugiem par šo preci:
Thyroid Cancer: From Emergent Biotechnologies to Clinical Practice Guidelines 1. izdevums
Pasūtīts no attālās noliktavas
Mūsu klienti saka:
Thyroid Cancer: From Emergent Biotechnologies to Clinical Practice Guidelines
The current age of clinical medicine is witnessing biotechnological innovation at an unprecedented pace. As a result, the recently popularized clinical practice guidelines (CPG), as a tool to assist clinical decision-making, have been struggling to keep up. Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines rides the wave of medical innovation, analyzing current and future CPG, and providing an up-to-date and comprehensive treatise on thyroid cancer, its diagnosis, and treatment.
A synthesis of ideas by prominent world experts in the field of thyroid cancer research and clinical practice, Thyroid Cancer covers:
Diagnostic techniques employed in the detection and follow-up of thyroid cancer including ultrasound, needle aspiration techniques, CT, PET, PET-CT, and MRI
Basic principles of systems biology, molecular and translational medicine, CPG development, and risk stratification for thyroid cancer
How CPG contain knowledge gaps and produce uncertainty
Advances in the field, including new surgical techniques, molecular targeted therapies, external beam radiation therapy, and chemotherapy
A comprehensive, scientific description of current and future diagnostic and therapeutic modalities for the management of thyroid cancer, this treatise is an indispensible reference for both the specialist and referring physician.
408 pages
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2019. gada 21. oktobris |
| ISBN13 | 9780367382711 |
| Izdevēji | Taylor & Francis Ltd |
| Lapas | 408 |
| Izmēri | 252 × 177 × 29 mm · 876 g |
| Valoda | Angļu |
| Redaktors | Carpi, Angelo |
| Redaktors | Mechanick, Jeffrey I |
